|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10821944 |
SNP |
PedAM |
snpId=rs10821944; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=ARID5B; CHROMOSOME=10; POS=62025330; REF=G; ALT=T |
details
|
|
|
rs10841845 |
SNP |
PedAM |
snpId=rs10841845; pubmedId=22932191; geneId=1421; geneSymbol=CRYGD; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The SNP rs10841845 G allele appears to have protective effect against anti-CCP-positive RA and confer reduced RA activity in men.; score=0.021986792; Year=2012; geneSymbol_dbSNP=CLEC4E; CHROMOSOME=12; POS=8533837; REF=A; ALT=G |
details
|
|
|
rs10865035 |
SNP |
PedAM |
snpId=rs10865035; pubmedId=22983539; geneId=3899; geneSymbol=AFF3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=By targeting a variant with convincing evidence for association with rheumatoid arthritis, significant association of AFF3 rs10865035 with SLE was detected in the Chinese population, indicating that AFF3 might be a common autoimmunity gene.; score=0.129001189; Year=2012; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100219272; REF=A; ALT=G |
details
|
|
|
rs10865035 |
SNP |
PedAM |
snpId=rs10865035; pubmedId=20453842; geneId=3899; geneSymbol=AFF3; diseaseId=umls:C0003873; sourceId=GAD; sentence=[We also refined associations at two established rheumatoid arthritis risk loci (IL2RA and CCL21) and confirmed the association at AFF3.]; score=0.129001189; Year=2010; geneSymbol_dbSNP=LINC01104; CHROMOSOME=2; POS=100219272; REF=A; ALT=G |
details
|
|
|
rs10903323 |
SNP |
PedAM |
snpId=rs10903323; pubmedId=20617525; geneId=401637; geneSymbol=OR7E26P; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We detected a novel genetic association between RA and the MSRA gene (rs10903323) in the Spanish combined population (P = 2.91 ¡Á 10(-5) , odds ratio [OR] 1.51).; score=0.000271442; Year=2010; geneSymbol_dbSNP=MSRA; CHROMOSOME=8; POS=10292057; REF=A; ALT=G |
details
|
|
|
rs10903323 |
SNP |
PedAM |
snpId=rs10903323; pubmedId=22657383; geneId=4482; geneSymbol=MSRA; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.; score=0.000814326; Year=2012; geneSymbol_dbSNP=MSRA; CHROMOSOME=8; POS=10292057; REF=A; ALT=G |
details
|
|
|
rs10903323 |
SNP |
PedAM |
snpId=rs10903323; pubmedId=23244167; geneId=1401; geneSymbol=CRP; diseaseId=umls:C0003873; sourceId=BeFree; sentence=In stratification analyses, a significantly increased risk for RA associated with the MSRA rs10903323 GA genotype was evident among male patients, older patients, C-reactive protein (CRP)-positive patients, and anti-cyclic citrullinated peptide (anti-CCP) negative patients compared with the MSRA rs10903323 GG genotype.; score=0.232003854; Year=2013; geneSymbol_dbSNP=MSRA; CHROMOSOME=8; POS=10292057; REF=A; ALT=G |
details
|
|
|
rs10919563 |
SNP |
PedAM |
snpId=rs10919563; pubmedId=21952740; geneId=7124; geneSymbol=TNF; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Presence of the rs10919563 RA susceptibility variant at the PTPRC gene locus predicts improved response to anti-TNF biologic therapy.; score=0.425384406; Year=2012; geneSymbol_dbSNP=PTPRC; CHROMOSOME=1; POS=198731313; REF=G; ALT=A |
details
|
|
|
rs10919563 |
SNP |
PedAM |
snpId=rs10919563; pubmedId=21952740; geneId=5788; geneSymbol=PTPRC; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Presence of the rs10919563 RA susceptibility variant at the PTPRC gene locus predicts improved response to anti-TNF biologic therapy.; score=0.130553895; Year=2012; geneSymbol_dbSNP=PTPRC; CHROMOSOME=1; POS=198731313; REF=G; ALT=A |
details
|
|
|
rs10945919 |
SNP |
PedAM |
snpId=rs10945919; pubmedId=18615156; geneId=9444; geneSymbol=QKI; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.]; score=0.002367032; Year=2008; geneSymbol_dbSNP=NA; CHROMOSOME=6; POS=163765645; REF=A; ALT=G |
details
|
|
|
rs10985070 |
SNP |
PedAM |
snpId=rs10985070; pubmedId=24390342; geneId=26147; geneSymbol=PHF19; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genetics of rheumatoid arthritis contributes to biology and drug discovery.; score=0.122638474; Year=2013; geneSymbol_dbSNP=PHF19; CHROMOSOME=9; POS=120873843; REF=C; ALT=A |
details
|
|
|
rs11051970 |
SNP |
PedAM |
snpId=rs11051970; pubmedId=22491018; geneId=636; geneSymbol=BICD1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.]; score=0.002367032; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=12; POS=32384554; REF=G; ALT=T |
details
|
|
|
rs11096957 |
SNP |
PedAM |
snpId=rs11096957; pubmedId=20448286; geneId=7096; geneSymbol=TLR1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.002638474; Year=2010; geneSymbol_dbSNP=TLR10; CHROMOSOME=4; POS=38774870; REF=T; ALT=G |
details
|
|
|
rs11096957 |
SNP |
PedAM |
snpId=rs11096957; pubmedId=20448286; geneId=10333; geneSymbol=TLR6; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Several SNPs mapping to the TLR and NFkappaB signalling systems demonstrated association with anti-TNF response as a whole and, in particular, with response to etanercept. Validation of these findings in an independent cohort is now warranted.]; score=0.002367032; Year=2010; geneSymbol_dbSNP=TLR10; CHROMOSOME=4; POS=38774870; REF=T; ALT=G |
details
|
|
|
rs11203203 |
SNP |
PedAM |
snpId=rs11203203; pubmedId=20453842; geneId=53347; geneSymbol=UBASH3A; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.]; score=0.122367032; Year=2010; geneSymbol_dbSNP=UBASH3A; CHROMOSOME=21; POS=42416077; REF=G; ALT=A |
details
|
|
|
rs11203366 |
SNP |
PedAM |
snpId=rs11203366; pubmedId=17216583; geneId=23569; geneSymbol=PADI4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.; score=0.33168498; Year=2007; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17331039; REF=G; ALT=A |
details
|
|
|
rs11203367 |
SNP |
PedAM |
snpId=rs11203367; pubmedId=17216583; geneId=23569; geneSymbol=PADI4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.; score=0.33168498; Year=2007; geneSymbol_dbSNP=PADI4; CHROMOSOME=1; POS=17331121; REF=T; ALT=C |
details
|
|
|
rs11209026 |
SNP |
PedAM |
snpId=rs11209026; pubmedId=18647855; geneId=149233; geneSymbol=IL23R; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.; score=0.012811307; Year=2009; geneSymbol_dbSNP=IL23R; CHROMOSOME=1; POS=67240275; REF=G; ALT=A |
details
|
|
